Search: onr:"swepub:oai:DiVA.org:umu-41122" >
Small interfering R...
Small interfering RNA-directed targeting of toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity
- Article/chapterEnglish2009
Publisher, publication year, extent ...
-
Elsevier BV,2009
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:umu-41122
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-41122URI
-
https://doi.org/10.1016/j.molimm.2009.06.016DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
A major cause of tumor treatment failure is cancer cell metastasis. Toll-like receptor 4 (TLR4)-mediated signaling has been implicated in tumor cell invasion, survival, and metastasis in a variety of cancers. In this study, we investigated the biological roles of TLR4 in prostate metastatic cell invasion and survival, and the potential of gene silencing of TLR4 using small interfering RNA (siRNA) for treatment of cancer. In cultured human prostate cancer cell lines, TLR4 were higher PC3 and DU145 as compared with the poorly metastatic LNCaP indicating that up-regulation of TLR4 was positively correlated with metastasis of tumor cell. In the highly metastatic cancer cell PC3, gene silencing of TLR4 using siRNA significantly inhibited TLR4 mRNA expression and protein level. Knockdown of TLR4 in PC3 cells resulted in a dramatic reduction of tumor cell migration and invasion as indicated by a Matrigel invasion assay. Furthermore, TLR4 siRNA suppressed cell viability and ultimately caused the induction of apoptotic cell death. The effects were associated with abrogating TLR4-mediated signaling to downstream target molecules such as myeloid differentiation factor 88 (MyD88), adaptor-inducing IFN-beta (TRIF), and interferon regulatory factor-1 (IRF-1). In a mouse prostate cancer model, administration with the plasmid construct expressing siRNA for TLR4 obviously inhibited established tumor growth and survival. These studies revealed evidence of a multifaceted signaling network operating downstream of TLR4-mediated tumor cell invasion, proliferation, and survival. Thus, RNA interference-directed targeting of TLR4 may raise the potential of its application for cancer therapy.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Liu, Meng-Yuan
(author)
-
Cheng, Zhi-de
(author)
-
Qin, Xiang-Jing
(author)
-
Zhang, Hai-Mou
(author)
-
Chen, Yong
(author)
-
Qin, Gang-Jian
(author)
-
Liang, Gang
(author)
-
Li, JinanHarvard Medical School, Boston, MA, USA(Swepub:umu)jili0010
(author)
-
Han, Xiao-Feng
(author)
-
Liu, Dong-Xu
(author)
-
Harvard Medical School, Boston, MA, USA
(creator_code:org_t)
Related titles
-
In:Molecular Immunology: Elsevier BV46:15, s. 2876-28840161-58901872-9142
Internet link
Find in a library
To the university's database
- By the author/editor
-
Hua, Dong
-
Liu, Meng-Yuan
-
Cheng, Zhi-de
-
Qin, Xiang-Jing
-
Zhang, Hai-Mou
-
Chen, Yong
-
show more...
-
Qin, Gang-Jian
-
Liang, Gang
-
Li, Jinan
-
Han, Xiao-Feng
-
Liu, Dong-Xu
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Cell and Molecul ...
- Articles in the publication
-
Molecular Immuno ...
- By the university
-
Umeå University